Mettler-Toledo International, Inc. $MTD Shares Sold by Parsons Capital Management Inc. RI

Parsons Capital Management Inc. RI cut its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 2.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,501 shares of the medical instruments supplier’s stock after selling 60 shares during the quarter. Parsons Capital Management Inc. RI’s holdings in Mettler-Toledo International were worth $2,938,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. WPG Advisers LLC acquired a new position in Mettler-Toledo International during the first quarter worth about $41,000. Zions Bancorporation National Association UT acquired a new position in Mettler-Toledo International during the first quarter worth about $43,000. Golden State Wealth Management LLC boosted its position in Mettler-Toledo International by 583.3% during the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier’s stock worth $48,000 after acquiring an additional 35 shares during the last quarter. Sound Income Strategies LLC boosted its position in Mettler-Toledo International by 477.8% during the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after acquiring an additional 43 shares during the last quarter. Finally, Blue Trust Inc. boosted its position in Mettler-Toledo International by 520.0% during the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier’s stock worth $73,000 after acquiring an additional 52 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CFO Shawn Vadala sold 300 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total value of $397,500.00. Following the sale, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at approximately $6,750,875. The trade was a 5.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the business’s stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares in the company, valued at $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,827 shares of company stock valued at $2,371,208. Company insiders own 1.94% of the company’s stock.

Analysts Set New Price Targets

MTD has been the topic of a number of recent research reports. Robert W. Baird boosted their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Evercore ISI reduced their target price on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a research note on Monday, August 4th. Barclays began coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 24th. They set an “overweight” rating and a $1,325.00 target price on the stock. Bank of America lifted their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research note on Monday, September 22nd. Finally, Citigroup lifted their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Thursday, August 21st. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Moderate Buy” and an average price target of $1,325.56.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,288.39 on Thursday. The company’s 50 day simple moving average is $1,270.44 and its 200-day simple moving average is $1,185.39. The company has a market capitalization of $26.54 billion, a price-to-earnings ratio of 32.63, a price-to-earnings-growth ratio of 3.68 and a beta of 1.37. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,521.01.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. The business had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business’s revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the firm earned $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.